Troy Bremer, Ph.D.
CSO and Founder of PreludeDx
0:29 | Current Standard of DCIS Care |
1:07 | Role of Radiation Therapy for DCIS |
3:12 | DCISionRT Overview & Test Results Explanation |
5:04 | DCISionRT Validation Data Highlights |
16:24 | DCISionRT: Consistent RT Prediction |
18:58 | DCISionRT Clinical Summary |
20:09 | PREDICT Registry Summary |
21:06 | Future of DCISionRT |
Vincent Reid, MD, FACS
Medical Director, Hall-Perrine Cancer Center & Chairman of Surgery, Mercy Medical Center
22:46 | Speaker Introduction |
23:45 | Clinical Dilemma for Managing DCIS Patients |
26:45 | Case Studies |
33:50 | Conclusion: A Surgeon’s Perspective |
Q and A with the Panelists
36:19 | What does a DCISion Score of 3 mean for a patient? |
37:30 | Is DCISionRT covered by insurance? |
38:11 | How does DCISionRT work in different subtypes of patients? |
40:17 | How to incorporate DCISionRT into protocol with tumor boards? |
41:37 | Do unexpected recurrences occur in patients tested with DCISionRT? |
42:45 | How to best introduce DCISionRT for implementation in a multidisciplinary practice? |
44:36 | How does DCISionRT impact mastectomy considerations? |
46:16 | How do high DCISion Scores & large lesions impact treatment recommendations? |
47:20 | What are benefits of ordering DCISionRT on Pre-Surgical Biopsy Specimen? |
48:23 | What is the Turn Around Time? |
48:42 | How does DCISionRT help with decision between BCS + RT vs oncoplastic vs mastectomy? |